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Aim To compare A allele frequencies of the 845G>A muta-
tion of 10 Slavic populations in central, eastern, and south-
ern Europe between each other and with other European 
populations.
Methods The 845G>A mutation from the DNA of 400 Pol-
ish neonates collected in 2005-2006 was analyzed by poly-
merase  chain  reaction-restriction  fragment  length  poly-
morphism. The  data  were  compared  with  reports  from 
other countries.
Results  We  identified  381  GG  homozygotes,  18  GA 
heterozygotes, and 1 AA homozygote. The 845A allele fre-
quency was 2.5%, which makes the summary figure for 
Poland from this and previous studies 3.5%. The average 
prevalence for Poland and other West Slavic countries was 
3.6%, similar to Russia (inhabited by the East Slavs, 3.5%). 
The average prevalence in South Slavic countries was 2.2%, 
gradually decreasing from 3.6% in Slovenia to 0% in Bulgar-
ia, with a longitudinal linear gradient (adjusted R2 = 0.976, 
P < 0.001).
Conclusions The West and East Slavs, together with Fin-
land, Estonia, Germany, Austria, Hungary, Slovenia, and Cro-
atia, form a group with 845A allele frequencies between 
3% and 4%. In the South Slavs, there is a gradual decline in 
the prevalence of 845A allele from northwest to southeast, 
with a surprisingly exact east-west linear gradient.
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In 1996, two major HFE  gene  mutations  (845G>A  and 
187C>G) responsible for an inherited form of hemochro-
matosis were identified (1). Hereditary hemochromatosis 
is a common autosomal recessive disorder characterized 
by  increased  iron  absorption.  It  has  significant  clinical 
consequences such as liver cirrhosis, diabetes mellitus, 
arthropathy, cardiomyopathy, and endocrine dysfunction 
(2). A total of 60% to 96% of patients with hemochroma-
tosis in Europe have the mutation 845G>A in exon 4. This 
causes cysteine to tyrosine substitution at position 282 
(C282Y) of the polypeptide chain, resulting in destabiliza-
tion of one of the bridging sulfide molecules disrupting 
HFE binding to β2-macroglobulin (1,3). The HFE polypep-
tide chain loses its ability to bind to transferrin receptor, 
and this results in a 200-300% increase in iron absorption 
from  food. The  severity  of  symptoms  in  homozygotes 
is variable and depends on the race, age, sex, and diet 
(2,4,5). Merryweather-Clarke et al (6) reported the high-
est prevalence of 845A HFE in northwestern Europe (5.2 
to 10.1%), ie, Sweden, Norway, UK, and Ireland. In Finland, 
Hungary, Poland, Russia, Austria, Germany, Czech Repub-
lic, and Slovakia the prevalence was between 3.2 and 4%. 
In southern Europe (Greece, Romania, Italy, and Spain), 
the prevalence is very low (6-18) and in Turkey it is almost 
non-existent (7). According to more recent data, France 
(6.1%)  can  now  be  added  to  the  northwestern  group 
(19,20). As the major comparison of the prevalence be-
tween European countries by Merryweather-Clarke et al 
(6) included few data on Slavic populations, we further 
assessed the 845A HFE frequency in the Polish population 
and compared it with other Slavic populations and previ-
ously published results, as well as determined its distribu-
tion across the entire Europe.
MAteriAlS And MethodS
The study sample comprised 400 consecutively born neo-
nates (187 female and 312 male) delivered at the Neona-
tology Department, Pomeranian Medical University, Szc-
zecin, Poland in 2005-2006. All neonates were of Polish 
origin, with Polish grandparents, and informed consent 
was obtained from all parents. The Ethical Committee of 
the Pomeranian Medical University approved the protocol 
of the study (BN- 001/57/05). Genomic DNA from neonates 
was extracted from 100 μL of umbilical cord blood using 
the QIAamp DNA Blood Mini Kit (QIAGEN, Hilden, Germa-
ny). For identification of the 845G>A HFE mutation, we 
used polymerase chain reaction (PCR)-restriction frag-
ment length polymorphism. About 20 ng of genomic 
DNA was used with a PCR mixture (10 μL) contain-
ing 10 × buffer (pH 8.3, 1.5 mM MgCl2), 0.2 mM each of the 
deoxynucleoide triphosphates, 0.5 U Polymerase Taq (MBI 
Fermentas, Vilnius, Lithuania), and 4 pmol each of the for-
ward and reverse primers. 5’- CCT CAT CCT TCC TCT TTC 
CT-3` was used as a forward primer and 5’- TCC TCA GGC 
ACT CCT CTC AA-3` as a reverse primer (TIB MOL BIOL, 
Poznan, Poland). PCRs were performed in a Mastercycler 
Gradient  thermal  cycler  (Eppendorf,  Hamburg,  Germa-
ny), with the following temperature profiles: initial dena-
turation at 94°C for 5 minutes, 37 cycles of 20 seconds at 
94°C, 40 seconds at 54°C, and 40 seconds at 72°C; with a 
final extension step at 72°C for 8 minutes. Amplification 
was followed by digestion of the 367 bp product using 
the RsaI restriction enzyme (5’-GT’AC-3’) (MBI Fermentas) 
for 3.5 hours at 37°C. PCR digestion products were sepa-
rated on 3% agarose gels, stained with ethidium bromide, 
and recorded using a DS-34 Polaroid Instant Camera (Po-
laroid, Dreieich, Germany) under UV light (Transillumina-
tor 4000, Stratagene, La Jolla, CA, USA). The RsaI digestion 
yields fragments of 225 and 142 bp for G845 homozy-
gotes; 225, 142, 113, and 29 bp for heterozygotes; or 225, 
113, and 29 bp for 845A homozygotes. Genotypes of GA 
and AA patients were also confirmed by DNA sequencing 
(3100-Avant Genetic Analyzer, Applied Biosystems Hitachi, 
Foster City, CA, USA).
Statistical analysis
Geographical coordinates (longitude) used in the analy-
sis were derived from Google maps (Google Inc, Moun-
tain View, CA, USA), except in cases of South Slavic coun-
tries, where additional sources were used for Serbia and 
Montenegro  (http://www.mapcrow.info/cgi-bin/cities_
distance_airpt.cgi?city3=9173706%2C00&city4=135261
%2C00) and other South Slavic countries (http://univer-
simmedia.pagesperso-orange.fr/geo/loc.htm).  Graphical 
materials were developed using Designworks software 
(GSP Ltd, London, UK) and Microsoft Office (Microsoft, 
Redmond, WA, USA). Linear regression analysis was per-
formed using STATISTICA, version 8.0 (StatSoft, Inc, Tulsa, 
OK, USA, www.statsoft.com), with the significance level 
set at P < 0.05.
reSultS
The frequency of the 845A allele in 400 Polish neonates 
was 2.5%. The 845G>A genotype distribution was 381 GG 
homozygotes, 18 GA heterozygotes, and 1 AA homozy-
gote. The 845G>A genotype distribution conformed to 
the expected Hardy-Weinberg equilibrium. The frequen-353 Adler et al: 845G>A HFE and Slavic populations
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cy of 845A HFE in 10 Slavic countries varied from 2.5% to 
5.0% (Table 1).
The average prevalence of 845A allele in the countries in-
habited by the West Slavs was 3.6% and varied from 3.5% 
in Poland (including our study) through 3.8% in the Czech 
Republic to 4.0% in Slovakia (10,14,21-23) (Figure 1). This 
places the West Slavs to a group with allele frequencies be-
tween 3% and 4%, together with East Slavic Russia (3.5%) 
and Finland, Estonia, Germany, Austria, Hungary, Slovenia, 
and Croatia.
The average prevalence of the 845A allele in South Slav-
ic countries was 2.2%. The highest prevalence was ob-
served in Slovenia (3.6%) (24-26), after which a gradual 
northwest-southeast  decrease  was  observed:  3.4%  in 
Croatia, 2.2% in Bosnia and Herzegovina, 1.6% in Serbia 
and Montenegro, 1.0% in Macedonia, and 0% in Bulgaria 
(27-30,32,33). When allele frequency was plotted against 
geographical longitude, a surprisingly exact east-west lin-
ear gradient was obtained (adjusted R2 = 0.976, P < 0.001; 
Figure 2).
diSCuSSion
Our study showed that the distribution of 845A HFE among 
Slavic countries was bi-modal. The West and East Slavs had 
a similar prevalence as other central and eastern Europe-
an populations, with values ranging between 3% and 4%. 
The South Slavs exhibited a linear decreasing west-to-east 
trend, with a prevalence varying from 3.6% to 0%.
Population migrations in Europe have led to the distri-
bution of ethnic groups and cultures, and consequently 
to genetic mixing (68). Migrations, together with other 
factors, have also determined the prevalence of genet-
ic diseases, such as hemochromatosis (68). Initially, the 
mutation 845G>A HFE  was  described  in  populations 
of northwestern European origin and has spread to 
territories inhabited by the Celts (68). On the other 
tABle 1. Allele frequencies for 845G>A HFE in Slavic countries
number of participants Frequency of 845A allele (%)
Population reference per study
sum per 
country
per 
study
per 
country*
West Slavs
Poland Present study 400 (neonates)
2788
2.5 3.5
Raszeja-Wyszomirska J et al, 2008 (21) 1517 (healthy adults) 4.0
Moczulski DA et al, 2001 (22) 871 (healthy adults) 3.1
Czech Republic Cimburová M et al, 2005 (14) 481 (neonates)
  620
3.4 3.8
Zdárský E et al, 1998 (10) 139 (healthy adults) 5.0
Slovakia Gabrikova D et al, 2011 (23) 359 (general population)   359 4.0 4.0
South Slavs
Slovenia Cukajti M et al, 2007 (24) 1282 (blood donors)
1779
3.6 3.6
Hruškovičová H et al, 2005 (25) 115 (healthy adults) 3.0
Zorc M et al, 2004 (26) 182 (adults) 4.1
Ristić S et al, 2003 (27) 200 (blood donors) 3.3
Croatia Starčević- Čizmarević N et al, 2006 (28) 350 (healthy adults)
  550
3.4 3.4
Ristić S et al, 2003 (27) 200 (healthy adults) 3.3
Bosnia and Herzegovina Terzić R et al, 2006 (29) 200 (blood donors)   400 2.0 2.2
Hercegovac A et al, 2008 (30) 200 (healthy adults) 2.3
Serbia and Montenegro Šarić M et al, 2006 (31) 318 (healthy adults)   318 1.6 1.6
Macedonia Arsov T et al, 2005 (32) 100 (healthy adults)   100 1.0 1.0
Bulgaria Ivanova A et al, 1999 (33) 100 (healthy adults)   100 0.0 0.0
east Slavs
Russia (European part) Kondrashova V et al, 2006 (34) 260 (healthy women)
1100
3.3 3.5
Pothekina E S et al, 2005 (35) 840 (blood donors) 3.5
Belarus no data
Ukraine no data
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hand, the 845G>A mutation might have originated from 
the Germanic Iron Age population in southern Scandina-
via and spread with the Vikings (37,68). In either case, this 
would result in lower 845A allele prevalence in the areas 
where their expansion was limited: central Europe, the 
Balkans, and Mediterranean countries.
Our study, together with the study by Merryweather-Clarke 
et al (6), suggests that a group of countries in central and 
east Europe have similar prevalence of the mutation. To our 
knowledge, this is the first comprehensive comparison of 
the 845A HFE mutation prevalence between all West and 
South Slavic populations.
Among the South Slavs, there was a linear gradual decrease 
in the prevalence of allele 845A HFE. This linearity suggests 
a possible stability and demic diffusion of the genes from 
the northwest into a block (the South Slavs) in which there 
are no conditions for the maintenance of a high frequency 
of the mutation (either because of genetic background or 
environmental reasons). An alternative explanation is that 
there is a gradient of conditions to which South Slavic pop-
ulations have been exposed, forming a gradient of positive 
selection and heterozygous advantage. A third possibility, 
perhaps supported by Y-chromosome haplotypes, is that 
the medieval expansion of the Slavs (beginning during the 
5th and 6th century) resulted in a gradient of ancestors 
carrying this allele (69).
It would be interesting to see if such a gradient is found 
with mutations in other genes and to compare this with 
genetic distance data both among the Southern Slavs and 
the  surrounding  populations.  Additionally,  a  spatial  fre-
quency distribution map constructed using intra-country 
regions would be of benefit – especially as a gradient simi-
lar to the one described here (but across one country) has 
been found in Portugal (57). It would also be interesting 
to fill in the gaps for the East Slavic populations, including 
those in Belarus, Ukraine, and the West Slavic group in Ger-
many (the Sorbs).
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Figure 1.
Allele frequencies for the 845G>A HFE mutation. Global averages for 
countries inhabited by the West Slavs – dashed line, South Slavs – low-
er solid thick line, and east Slavs – upper solid thick line (references as 
in table 1). Global averages for other countries – Austria (36), denmark 
(37), estonia (38,39), Finland (7,40-42), France (19,20), Greece (7), Germa-
ny (7-9), hungary (43), iceland (7,44), both (45), ireland (6,7,46-48), italy 
(7,12,13,15,16,49-52),  netherlands  (53,54),  norway  (7,55,56),  Portugal 
(57), romania (18), Spain (7,11,17,58-61), Sweden (40), Switzerland (62), 
turkey (7), uK (6,7,63-67). n.d. – no data.
Figure 2.
linear trend in the frequency of 845A HFE with increase in longitude. 1 – 
Slovenia; 2 – Croatia; 3 – Bosnia and herzegovina; 4 – Serbia and Monte-
negro; 5 – Macedonia; 6 – Bulgaria. Adjusted r2 = 0.976, P < 0.001355 Adler et al: 845G>A HFE and Slavic populations
www.cmj.hr
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